MGC Pharmaceuticals Top Insiders
MGC Pharmaceuticals employs about 16 people. The company is managed by 10 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 1.6 employees per reported executive. Examination of MGC Pharmaceuticals' management performance can provide insight into the company performance.
| Roby Zomer CEO CEO, Executive Director |
MGC |
MGC Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.4527) % which means that it has lost $0.4527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.1854) %, meaning that it generated substantial loss on money invested by shareholders. MGC Pharmaceuticals' management efficiency ratios could be used to measure how well MGC Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.MGC Pharmaceuticals Workforce Comparison
MGC Pharmaceuticals is regarded second in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 8,725. MGC Pharmaceuticals adds roughly 16.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
MGC Pharmaceuticals Notable Stakeholders
A MGC Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MGC Pharmaceuticals often face trade-offs trying to please all of them. MGC Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MGC Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Roby Zomer | CEO, Executive Director | Profile | |
| Yifat Steuer | Deputy COO | Profile | |
| Robert Clements | Chief Officer | Profile | |
| AngelaMarie Graham | Group Officer | Profile | |
| Yair Tal | Chief Officer | Profile | |
| Sasha Friedman | Deputy CEO | Profile | |
| Sabina Suljakovic | Head Department | Profile | |
| Amir Polak | Chief Officer | Profile | |
| Nadya Lisovoder | Chief Officer | Profile | |
| Nicole Godresse | Global Officer | Profile |
MGC Pharmaceuticals Workforce Analysis
Traditionally, organizations such as MGC Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MGC Pharmaceuticals within its industry.MGC Pharmaceuticals Manpower Efficiency
Return on MGC Pharmaceuticals Manpower
| Revenue Per Employee | 290.4K | |
| Revenue Per Executive | 464.7K | |
| Net Loss Per Employee | 1.3M | |
| Net Loss Per Executive | 2M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in MGC OTC Stock
If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |